Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...

A nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...

The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per 28 mg device and costs around $32,400 for a year’s treatment, says ICER.

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.

TBI occurs when the brain is damaged by an external force, like a nasty tackle or a hard punch (or getting pulled over by ...

The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and ...

When a cold leaves you stuffed up, you can get fast relief from a nasal spray. But take a minute to learn the different types and how to use them. It can make all the difference in effectively ...

Nasal Spray 10mg, is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in ...